Category: Infectious Diseases
Global Infectious Diseases
-
Custom Antibody Market by Service (Development, Purification, Fragmentation, Labeling), Type (mAbs, pAbs, rAbs), Source (Rabbit, Mice), Application (Research, Therapeutics), Indication (Oncology, Immunology, Infectious, CVD) - Global Forecast to 2029
... to reach USD 901 million in 2029 from USD 579 million in 2024, at a CAGR of 9.2% during the forecast period. The growth of this market can be attributed to the increasing prevalence of ... Read More
-
Global Hospital Infection Therapeutics Market 2024-2028
... period. Our report on the hospital infection therapeutics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors. The report offers an ... Read More
-
Global Antibiotics Market 2024-2028
... holistic analysis, market size and forecast, trends, growth drivers, challenges, and vendor analysis covering around 25 vendors. The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the ... Read More
-
Emerging Infectious Disease Diagnostics Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Application (Laboratory Testing and Point of Care Testing), By Technology (Polymerase chain reaction, Immunodiagnostics, Isothermal Nucleic Acid Amplification Technology (INAAT), Next-Generation Sequencing (NGS), and Others), By Type of Infection (Bacterial, Viral, Fungal, and Others), By Disease Type (Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), and Others), By End user (Hospitals & Clinics, Diagnostic laboratories, and Others), By Region and Competition, 2019-2029F
... (INAAT), Next-Generation Sequencing (NGS), and Others), By Type of Infection (Bacterial, Viral, Fungal, and Others), By Disease Type (Respiratory Infections, Gastrointestinal Infections, Sexually Transmitted Infections (STIs), and Others), By End user (Hospitals & Clinics, Diagnostic ... Read More
-
RNA Therapeutics Market Assessment, By Type [RNA Interference Therapeutics, mRNA Therapeutics, Antisense Oligonucleotide Therapeutics, Others], By Product [Vaccines, Drugs], By Indication [Rare Genetic Diseases/Hereditary Diseases, Infectious Diseases, Others], By End-user [Hospitals, Academic Research Centers, Contract Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F
... Research Organizations, Others], By Region, Opportunities and Forecast, 2017-2031F Global RNA therapeutics market size was valued at USD 23,067.85 million in 2023, expected to reach USD 54,464.95 million in 2031, with a CAGR of 11.25% ... Read More
-
Injectable Drug Delivery Market by Type (Device, Formulation), Therapeutic (Infectious diseases,Cancer), Usage Pattern (Immunization), Administration (Skin, Musculoskeletal), Distribution Channel ,Patient Care Setting, & Region - Global Forecast to 2029
... is projected to reach USD 1139.4 billion by 2029 from USD 754.5 billion in 2024, at a CAGR of 8.6% from 2024 to 2029. The increased prevalence of chronic diseases such as diabetes, cancer, autoimmune ... Read More
-
Global Zika Virus Testing Market Analysis and Forecast 2024-2030
... virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika are fever, rash, joint ... Read More
-
Global Hospital Acquired Infections Therapeutic Databank Market Report
... 2.02% from 2023 to 2031. Antibacterial Drugs segment is expected to be the highest contributor to this market, with $9,937.3 Million in 2022, and is anticipated to reach $11,555.8 Million by 2031, registering a CAGR ... Read More
-
Global Zika Virus Testing Market Size, Manufacturers, Growth Analysis Industry Forecast to 2030
... Test/ Serological Test. Zika virus (Zika) is a disease caused by the Zika virus, which is spread to people primarily through the bite of an infected Aedes species mosquito. The most common symptoms of Zika ... Read More
-
Hospital Acquired Pneumonia (HAP) - Global Clinical Trials Review, 2024
... scenario. This report provides top line data relating to the clinical trials on Hospital Acquired Pneumonia (HAP). Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. ... Read More
-
Medical Microbiology Testing Technologies Market (Indication: Respiratory Diseases, Neurological Diseases, Infectious Diseases, and Others; and Technology: Cell Culture, Microscopy, and Serology) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034
... Technologies Market – Scope of Report TMR’s report on the global medical microbiology testing technologies market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators ... Read More
-
Targeted Sequencing Market - Global Industry Size, Share, Trends, Competition, Opportunity, and Forecast, Segmented By Product Type (Kits/Panels and Assays, Instruments and Other), By Target Enrichment Method (Amplicon Sequencing, Hybridization Capture, and Others), By Target Capture Type (Targeted DNA Sequencing ,Targeted RNA Sequencing and others), By Application(Oncology, Infectious Diseases, Cardiovascular Diseases, Reproductive Health, Rare Diseases, Neurological Disorders, Hereditary Diseases, and Others), By End Users (Academic and Research Institution, Pharmaceutical and Biotech Companies, Diagnostic & Clinical Laboratories and Other), By Region, By Competition, 2019-2029F
... Capture Type (Targeted DNA Sequencing ,Targeted RNA Sequencing and others), By Application(Oncology, Infectious Diseases, Cardiovascular Diseases, Reproductive Health, Rare Diseases, Neurological Disorders, Hereditary Diseases, and Others), By End Users (Academic and Research Institution, Pharmaceutical and ... Read More
-
Point of Care Infectious Disease Global Market Insights 2024, Analysis and Forecast to 2029, by Manufacturers, Regions, Technology
... and its CAGR from 2019 to 2023, and also forecasts its market size to the end of 2029 and its CAGR from 2024 to 2029. For geography segment, regional supply, demand, major players, price is ... Read More
-
Global Immunodiagnostics Market Size Study & Forecast, by Product (Instruments, Reagents & Consumables), By Application (Oncology & Endocrinology, Hepatitis & Retrovirus, Cardiac Markers, Infectious Diseases, Others), By End user (Clinical Laboratories, Hospitals, Physician’s Offices, Others), and Regional Analysis, 2023-2030
... and Regional Analysis, 2023-2030 Global Immunodiagnostics Market is valued approximately at USD 17.83 billion in 2022 and is anticipated to grow with a growth rate of more than 7.30% over the forecast period 2023-2030. Immunodiagnostics ... Read More
-
Global Artificial Intelligence (Ai) In Epidemiology Market Forecast 2024-2032
... facilitating the market’s growth include the early detection and surveillance of disease outbreaks, the growing need for predictive modeling to forecast disease trends, and data availability for epidemiological research. MARKET INSIGHTS Early detection and surveillance ... Read More
-
In Vitro Diagnostics Market by Product & Service (Instruments, Kits, Software), Technology (Immunoassay, Hematology, Urinalysis), Specimen (Blood, Saliva), Test Type, Application (Oncology, Autoimmune, CVD, Infectious Diseases) - Global Forecast to 2029
... diagnostics market is projected to reach USD 119.4 billion by 2029 from USD 85.2 billion in 2024, at a CAGR of 6.9% during the forecast period. With the rapid growth in the geriatric population globally, ... Read More
-
Global Pneumonia Vaccine Market Growth 2024-2030
... Vaccine is forecast to a readjusted size of US$ million by 2030 with a CAGR of % during review period. The research report highlights the growth potential of the global Pneumonia Vaccine market. Pneumonia Vaccine ... Read More
-
2024 Global Forecast for Microneedle Flu Vaccine Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD xx billion in ... Read More
-
2024 Global Forecast for Measles, Mumps And Rubella (Mmr) Vaccines Market (2025-2030 Outlook)-High Tech & Emerging Markets Report
... 50 countries. The product or service category is within the NAICS Medical Laboratories industry. The product or service category is within the NAICS Medical Laboratories industry. The global market is expected to increase from USD ... Read More
-
RNAi Drug Delivery Market Size, Trends, Analysis, and Outlook By Technology (Nanoparticle drug delivery, Pulmonary drug delivery, Nucleic acid drug delivery, Aptamer drug delivery), By Application (Infectious diseases, Oncology, Cardiology, Neurology, Others), by Region, Country, Segment, and Companies, 2024-2030
... Segment, and Companies, 2024-2030 The global RNAi Drug Delivery market size is poised to register 17.5% growth (CAGR) from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. The industry study ... Read More
-
Immunodiagnostics Market Assessment, By Type [Radioimmunoassay, ELISA, Chemiluminescent immunoassay, Fluorescent immunoassay, Lateral flow assay, Rapid Test, Others], By Product [Reagents, Instruments, Software & Services], By Application [Oncology, Endocrinology, Infectious diseases, Allergy, Autoimmune Diseases, Environmental Pollution, Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F
... Food Technology, Proteomics, Cardiac Biomarker, Drug Monitoring, Others], By End-user [Hospitals, Clinical Laboratories, Academics & Research Centers, Pharma & Biotech Industry, Others], By Region, Opportunities and Forecast, 2017-2031F Global immunodiagnostics market size was valued at ... Read More
-
Viral Vector Production Market Size, Trends, Analysis, and Outlook By Indication (Cancer, Genetic Disorders, Infectious Diseases, Other Diseases), By Application (Gene Therapy, Vaccinology), By Viral Vector (Adenoviral Vectors, Lentiviral Vectors, Retroviral Vectors, Adeno-Associated Viral Vectors, Others), by Region, Country, Segment, and Companies, 2024-2030
... Others), by Region, Country, Segment, and Companies, 2024-2030 The global Viral Vector Production market size is poised to register 17.68% growth from 2024 to 2030, presenting significant growth prospects for companies operating in the industry. ... Read More
-
Cell and Gene Therapy Bioanalytical Testing Services Market Size, Trends, Analysis, and Outlook By Test Type (Bioavailability & Bioequivalence Studies, Pharmacokinetics, Pharmacodynamics, Others), By Product (Gene Therapy, Gene-Modified Cell Therapy, Cell Therapy), By Stage Of Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030
... Development (Non-Clinical, Clinical), By Indication (Oncology, Infectious Diseases, Neurological disorders, Rare Diseases, Others), by Region, Country, Segment, and Companies, 2024-2030 The global Cell and Gene Therapy Bioanalytical Testing Services market size is poised to register ... Read More
-
Point of Care Infectious Disease Testing Market Size, Trends, Analysis, and Outlook By Disease (HIV POC, Clostridium difficile POC, HBV POC, Pneumonia or Streptococcus associated infections, Respiratory syncytial virus (RSV) POC, HPV POC, Influenza/Flu POC, HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030
... HCV POC, MRSA POC, TB and drug-resistant TB POC, HSV (Herpes Simplex Virus) POC, Others), By End-user (Hospitals, Clinics, Home, Assisted Living Healthcare Facilities, Laboratories, Others), by Region, Country, Segment, and Companies, 2024-2030 The global ... Read More
-
Global Hospital Acquired Pneumonia Drugs Market Growth 2024-2030
... in downstream market, the Hospital Acquired Pneumonia Drugs is forecast to a readjusted size of US$ 3059.9 million by 2030 with a CAGR of 1.6% during review period. The research report highlights the growth potential ... Read More